Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury

Cardiovascular Toxicology

Volumn 12, Issue 4, 2012, Pages 350-358

  Gong, Dingxu ^a   Zhang, Yujian ^a   Zhang, Hao ^b   Gu, Haiyong ^a   Jiang, Qin ^a   Hu, Shengshou ^a  

^a FUWAI HOSPITAL   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Aldehyde dehydrogenase 2; Cardioplegia solution; Cardioprotection; Ischemia and reperfusion

Indexed keywords

4 HYDROXYNONENAL; ALDA 1; ALDEHYDE DEHYDROGENASE 2 AGONIST; ALDEHYDE DEHYDROGENASE ISOENZYME 2; ALDEHYDE DERIVATIVE; CARBONYL DERIVATIVE; CARDIOPLEGIC AGENT; CREATINE KINASE MB; GLUTARIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; HISTIDINE; MALONALDEHYDE; OXOGLUTARIC ACID; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EX VIVO STUDY; HEART CONTRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; MALE; METABOLIC PARAMETERS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SHAM PROCEDURE;

ALDEHYDE DEHYDROGENASE; ANIMALS; BENZAMIDES; BENZODIOXOLES; CARDIOPLEGIC SOLUTIONS; CARDIOTONIC AGENTS; ENZYME ACTIVATION; HEART ARREST; HEART ARREST, INDUCED; MALE; MITOCHONDRIAL PROTEINS; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; UP-REGULATION;

RATTUS;

EID: 84870564342     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-012-9179-6     Document Type: Article

References (31)

1. Milei, J., Grana, D. R., Forcada, P., & Ambrosio, G. (2007). Mitochondrial oxidative and structural damage in ischemiareperfusion in human myocardium. Current knowledge and future directions. Frontiers in Bioscience, 12, 1124-1130.
2. Hill, B. G., & Bhatnagar, A. (2009). Beyond reactive oxygen species: Aldehydes as arbitrators of alarm and adaptation. Circulation Research, 105, 1044-1046.
3. Fukai, M., Hayashi, T., Yokota, R., Shimamura, T., Suzuki, T., Taniguchi, M., et al. (2005). Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver. Free Radical Biology and Medicine, 38, 1372-1381.
4. Farout, L., Mary, J., Vinh, J., Szweda, L. I., & Friguet, B. (2006). Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20 s proteasome subtypes. Archives of Biochemistry and Biophysics, 453, 135-142.
5. Chen, J., Henderson, G. I., & Freeman, G. L. (2001). Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. Journal of Molecular and Cellular Cardiology, 33, 1919-1927.
6. Lucas, D. T., & Szweda, L. I. (1999). Declines in mitochondrial respiration during cardiac reperfusion: Age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proceedings of the National academy of Sciences of the United States of America, 96, 6689-6693.
7. Bhatnagar, A. (2006). Environmental cardiology: Studying mechanistic links between pollution and heart disease. Circulation Research, 99, 692-705.
8. Chen, C. H., Budas, G. R., Churchill, E. N., Disatnik, M. H., Hurley, T. D., & Mochly-Rosen, D. (2008). Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science, 321, 1493-1495.
9. Gong, D., Zhang, H., & Hu, S. (2012). Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection. Journal ofMolecular and Cellular Cardiology. doi:10.1016/j.yjmcc.2012. 03.017.
10. Zhang, H., Gong, D. X., Zhang, Y. J., Li, S. J., & Hu, S. (2012). Effect of mitochondrial aldehyde dehydrogenase-2 genotype on cardioprotection in patients with congenital heart disease. European Heart Journal, 33, 1606-1614.
11. Goedde, H. W., Agarwal, D. P., Harada, S., Meier-Tackmann, D., Ruofu, D., Bienzle, U., et al. (1983). Population genetic studies on aldehyde dehydrogenase isozyme deficiency and alcohol sensitivity. American Journal of Human Genetics, 35, 769-772.
12. Enomoto, N., Takase, S., Yasuhara, M., & Takada, A. (1991). Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcoholism, Clinical and Experimental Research, 15, 141-144.
13. Braathen, B., Jeppsson, A., Schersten, H., Hagen, O. M., Vengen, O., Rexius, H., et al. (2011). One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: A prospective randomized study. Journal of Thoracic and Cardiovascular Surgery, 141, 995-1001.
14. Saitoh, Y., Hashimoto, M., Ku, K., Kin, S., Nosaka, S., Masumura, S., et al. (2000). Heart preservation in htk solution: Role of coronary vasculature in recovery of cardiac function. Annals of Thoracic Surgery, 69, 107-112.
15. Endo, J., Sano, M., Katayama, T., Hishiki, T., Shinmura, K., Morizane, S., et al. (2009). Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart. Circulation Research, 105, 1118-1127.
16. Castillo, R., Rodrigo, R., Perez, F., Cereceda, M., Asenjo, R., Zamorano, J., et al. (2011). Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation. Basic & Clinical Pharmacology & Toxicology, 108, 256-262.
17. Sampey, B. P., Carbone, D. L., Doorn, J. A., Drechsel, D. A., & Petersen, D. R. (2007). 4-hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (erk) and the inhibition of hepatocyte erk-est-like protein-1-activating protein-1 signal transduction. Molecular Pharmacology, 71, 871-883.
18. Ma, H., Li, J., Gao, F., & Ren, J. (2009). Aldehyde dehydrogenase 2 ameliorates acute cardiac toxicity of ethanol: Role of protein phosphatase and forkhead transcription factor. Journal of the American College of Cardiology, 54, 2187-2196.
19. Budas, G. R., Disatnik, M. H., Chen, C. H., & Mochly-Rosen, D. (2010). Activation of aldehyde dehydrogenase 2 (aldh2) confers cardioprotection in protein kinase c epsilon (pkcvarepsilon) knockout mice. Journal of Molecular and Cellular Cardiology, 48, 757-764.
20. Liao, J., Sun, A., Xie, Y., Isse, T., Kawamoto, T., Zou, Y., et al. (2012). Aldehyde dehydrogenase-2 deficiency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress induction. Molecular Medicine. doi:10.2119/molmed.2011.00466.
21. Ma, H., Guo, R., Yu, L., Zhang, Y., & Ren, J. (2011). Aldehyde dehydrogenase 2 (aldh2) rescues myocardial ischaemia/reperfusion injury: Role of autophagy paradox and toxic aldehyde. European Heart Journal, 32, 1025-1038.
22. Eaton, P., Li, J. M., Hearse, D. J., & Shattock, M. J. (1999). Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. American Journal of Physiology, 276, H935-H943.
23. Luckey, S. W., Tjalkens, R. B., & Petersen, D. R. (1999). Mechanism of inhibition of rat liver class 2 aldh by 4-hydroxynonenal. Advances in Experimental Medicine and Biology, 463, 71-77.
24. Petersen, D. R., & Doorn, J. A. (2004). Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radical Biology and Medicine, 37, 937-945.
25. Stewart, M. J., Malek, K., & Crabb, D. W. (1996). Distribution of messenger rnas for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. Journal of Investigative Medicine, 44, 42-46.
26. Sun, L., Ferreira, J. C., & Mochly-Rosen, D. (2011). Aldh2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance. Science Translational Medicine, 3, 107-111.
27. Chen, C. H., Sun, L., & Mochly-Rosen, D. (2010). Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovascular Research, 88, 51-57.
28. Luo, J., Hill, B. G., Gu, Y., Cai, J., Srivastava, S., Bhatnagar, A., et al. (2007). Mechanisms of acrolein-induced myocardial dysfunction: Implications for environmental and endogenous aldehyde exposure. American Journal of Physiology. Heart and Circulatory Physiology, 293, H3673-H3684.
29. van der Laarse, A., van der Wall, E. E., van den Pol, R. C., Vermeer, F., Verheugt, F. W., Krauss, X. H., et al. (1988). Rapid enzyme release from acutely infarcted myocardium after early thrombolytic therapy: Washout or reperfusion damage American Heart Journal, 115, 711-716.
30. Brooks, P. J., Enoch, M. A., Goldman, D., Li, T. K., & Yokoyama, A. (2009). The alcohol flushing response: An unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Medicine, 6, e50.
31. Perez-Miller, S., Younus, H., Vanam, R., Chen, C. H., Mochly-Rosen, D., & Hurley, T. D. (2010). Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nature Structural & Molecular Biology, 17, 159-164.